You Are Here: U.S. Preventive Services Task Force > Topic Index > Genetic Risk Assessment and BRCA Mutation Testing: Breast & Ovarian Cancer Susceptibility
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility
Release Date: September 2005
This topic page summarizes the U.S. Preventive Services Task Force (USPSTF) recommendations on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
Summary of Recommendations / Supporting Documents
Summary of Recommendations
- The U.S. Preventive Services Task Force (USPSTF)
recommends against routine referral for genetic counseling
or routine breast cancer susceptibility gene (BRCA)
testing for women whose family history is not associated
with an increased risk for deleterious mutations in breast
cancer susceptibility gene 1 (BRCA1) or breast cancer
susceptibility gene 2 (BRCA2).
Grade: D Recommendation. - The USPSTF recommends that women whose family
history is associated with an increased risk for deleterious
mutations in BRCA1 or BRCA2 genes be referred
for genetic counseling and evaluation for BRCA testing.
Grade: B Recommendation.
Supporting Documents
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility, September 2005
Recommendation Statement (PDF File, 220 KB; PDF Help)
Evidence Review (PDF File, 885 KB; PDF Help)
Evidence Synthesis (PDF File, 3.6 MB; PDF Help)
Current as of September 2005
Internet Citation:
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility, Topic Page. September 2005. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrgen.htm
USPSTF Program Office |
